Not provided
Not provided
Not provided
Not provided
Not provided
There could not be enough patients recruited
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Fibromyalgia is a common chronic pain syndrome characterized by bad treatable chronic widespread pain present at a similar level for at least 3 months. The aim of this study is to examine if 3 weeks of transcranial direct current stimulation is a suitable therapy to reduce chronic pain.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| transcranial direct current stimulation | Active Comparator | transcranial direct current stimulation of the primary motor cortex |
|
| sham treatment | Sham Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| transcranial direct current stimulation | Device |
| ||
| sham treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Visual Analoge Scale | Difference Baseline - after treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Quality of Life - SF-36 | baseline / after treatment / 1 , 2, 3 months after treatment | |
| Fibromyalgia Impact Questionaire | baseline / after treatment / 1,2,3, months after treatment | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michael Quittan, PhD | Karl Landsteiner Institute of Remobilisation and functional Health | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Karl Landsteiner Institute of Remobilisation and Functional Health | Vienna | State of Vienna | 1100 | Austria |
Not provided
Not provided
Not provided
Not provided
Not provided
| Device |
|
| IL-10 ELISA |
| baseline / after treatment / 1,2,3, months after treatment |
| Visual analog scale | 1,2,3 months after treatment |
| IL-6 ELISA | baseline / after treatment / 1,2,3, months after treatment |
| IL-4 ELISA | baseline / after treatment / 1,2,3, months after treatment |
| TNF-alpha ELISA | baseline / after treatment / 1,2,3, months after treatment |
| ID | Term |
|---|---|
| D005356 | Fibromyalgia |
| D059350 | Chronic Pain |
| ID | Term |
|---|---|
| D009135 | Muscular Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
| D009468 | Neuromuscular Diseases |
| D009422 | Nervous System Diseases |
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D065908 | Transcranial Direct Current Stimulation |
| ID | Term |
|---|---|
| D004599 | Electric Stimulation Therapy |
| D013812 | Therapeutics |
| D003295 | Convulsive Therapy |
| D013000 | Psychiatric Somatic Therapies |
| D004191 | Behavioral Disciplines and Activities |
| D004597 | Electroshock |
| D011580 | Psychological Techniques |
Not provided
Not provided